These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6331656

  • 1. Modification of the bone marrow toxicity of cis-diamminedichloroplatinum(II) in mice by diethyldithiocarbamate.
    Evans RG, Wheatley C, Engel C, Nielsen J, Ciborowski LJ.
    Cancer Res; 1984 Sep; 44(9):3686-90. PubMed ID: 6331656
    [Abstract] [Full Text] [Related]

  • 2. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF.
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modification of the sensitivity and repair of potentially lethal damage by diethyldithiocarbamate during and following exposure of plateau-phase cultures of mammalian cells to radiation and cis-diamminedichloroplatinum(II).
    Evans RG, Engel C, Wheatley C, Nielsen J.
    Cancer Res; 1982 Aug; 42(8):3074-8. PubMed ID: 6284357
    [Abstract] [Full Text] [Related]

  • 5. Diethyldithiocarbamate modulation of murine bone marrow toxicity induced by cis-diammine(cyclobutanedicarboxylato)platinum (II).
    Schmalbach TK, Borch RF.
    Cancer Res; 1989 Dec 01; 49(23):6629-33. PubMed ID: 2555048
    [Abstract] [Full Text] [Related]

  • 6. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 01; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of Cis-diamminedichloroplatinum (II) on hematopoietic stem cells in mice.
    Jenkins VK, Perry RR, Goodrich WE.
    Exp Hematol; 1981 Mar 01; 9(3):281-7. PubMed ID: 7194800
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb 01; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 14. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction.
    Inoue T, Hirabayashi Y, Mitsui H, Sasaki H, Cronkite EP, Bullis JE, Bond VP, Yoshida K.
    Exp Hematol; 1995 Nov 01; 23(12):1296-300. PubMed ID: 7589285
    [Abstract] [Full Text] [Related]

  • 15. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
    Soderberg LS, Flick JT, Barnett JB.
    Exp Hematol; 1996 Jun 01; 24(7):848-53. PubMed ID: 8647236
    [Abstract] [Full Text] [Related]

  • 16. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.
    Schmalbach TK, Borch RF.
    Cancer Res; 1989 May 15; 49(10):2574-7. PubMed ID: 2540902
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model.
    Alberts DS, Peng YM, Chen HS, Moon TE, Cetas TC, Hoeschele JD.
    J Natl Cancer Inst; 1980 Aug 15; 65(2):455-61. PubMed ID: 6931261
    [Abstract] [Full Text] [Related]

  • 18. Effects of diethyldithiocarbamate and nine other nucleophiles on the intersubunit protein cross-linking and inactivation of purified human alpha 2-macroglobulin by cis-diamminedichloroplatinum(II).
    Gonias SL, Oakley AC, Walther PJ, Pizzo SV.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5764-70. PubMed ID: 6209003
    [Abstract] [Full Text] [Related]

  • 19. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
    Schein PS, Green D, Dean SW, McPherson E.
    Cancer Res; 1987 Feb 01; 47(3):696-9. PubMed ID: 3802075
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
    Prajda N, Kralovánszky J, Gal F, Kiss F, Kerpel-Fronius S.
    In Vivo; 1989 Feb 01; 3(4):267-70. PubMed ID: 2519864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.